Indiana 2021 Regular Session Status: Passed Senate Bipartisan · 9 R · 1 D cosponsors

SB 131 — Disclosures related to prescription drugs.

Last action — First reading: referred to Committee on Financial Institutions and Insurance

  1. ✓
    Introduced
  2. ✓
    In Committee
  3. 3
    Passed Senate
  4. 4
    Passed House
  5. 5
    To Executive
  6. 6
    Enacted

This bill died with 2021 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.

This bill is no longer active — its legislative session has ended, so there are no live odds of enactment. It would have to be reintroduced in the current session to move again.

Summary

Beginning January 1, 2022, requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide to a covered individual the maximum allowable cost of a generic drug on the written materials provided at the point of sale. Provides that if an agreement between a health plan and a pharmacy benefit manager that is entered into or renewed after December 31, 2021, provides that less than 85% of the estimated rebates will be deducted from the cost of prescription drugs before a covered individual's cost sharing requirement is determined, the pharmacy benefit manager must provide the policyholder with a notice on an annual basis that includes: (1) an explanation of what a rebate is; (2) an explanation of how rebates accrue to the health plan from the manufacturer; and (3) the aggregate amount of rebates that accrued to the health plan for prescription drugs dispensed under the policyholder's health plan for the previous year.

Bill Text

We don't have the full text on file for this bill yet.

Read SB 131 on the official Indiana source →

Action History

  1. First reading: referred to Committee on Financial Institutions and Insurance

  2. Referred to the House

  3. Third reading: passed; Roll Call 150: yeas 32, nays 17

  4. House sponsor: Representative Vermilion

  5. Cosponsors: Representatives Davisson and Pressel

  6. Senators Charbonneau and Becker added as coauthors

  7. Second reading: amended, ordered engrossed

  8. Amendment #5 (Bohacek) prevailed; voice vote

  9. Committee report: amend do pass, adopted

  10. Senator Randolph added as coauthor

  11. Senator Grooms added as coauthor

  12. Senator Doriot added as coauthor

  13. Senator Baldwin added as coauthor

  14. Senator Freeman added as coauthor

  15. Senator Walker K added as third author

  16. Senator Alting added as second author

  17. Senator Bohacek added as author

  18. Senator Walker K removed as author

  19. Senator Bohacek removed as second author

  20. First reading: referred to Committee on Insurance and Financial Institutions

  21. Authored by Senators Walker K and Bohacek

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

4 sponsors · 9 co-sponsors · 137 not signed on

Sponsors (4)

Co-sponsors (9)

Not signed on (137)

137 members have not signed on to this bill.

Show all 137 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Subjects

healthcare health-insurance
Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does SB 131 do?
Beginning January 1, 2022, requires a state employee health plan, a policy of accident and sickness insurance, and a health maintenance organization contract to provide to a covered individual the maximum allowable cost of a generic drug on the written materials provided at the point of sale. Provides that if an agreement between a health plan and a pharmacy benefit manager that is entered into or renewed after December 31, 2021, provides that less than 85% of the estimated rebates will be deducted from the cost of prescription drugs before a covered individual's cost sharing requirement is determined, the pharmacy benefit manager must provide the policyholder with a notice on an annual basis that includes: (1) an explanation of what a rebate is; (2) an explanation of how rebates accrue to the health plan from the manufacturer; and (3) the aggregate amount of rebates that accrued to the health plan for prescription drugs dispensed under the policyholder's health plan for the previous year.
Who sponsors SB 131?
SB 131 is sponsored by Mike Bohacek (Republican), Ron Alting (Republican), Kyle Walker (Republican), Aaron Freeman (Republican), Scott Baldwin (Republican), Blake Doriot (Republican), Ronald Grooms, Lonnie Randolph (Democrat), Ed Charbonneau (Republican), Vaneta Becker (Republican), Ann Vermilion, Jim Pressel (Republican), and Davisson, J..
What is the current status of SB 131?
This bill died with 2021 Regular Session. It reached “Passed Senate” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
Where can I track SB 131?
Track SB 131 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on SB 131

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Find my representatives → Run a campaign

Stay ahead of SB 131

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →